1	Caffeine	Caffeine	B-NP	NN	O	2	SUB	-1
2	inhibits	inhibit	B-VP	VBZ	O	0	ROOT	18	inhibits
3	adenosine-induced	adenosine-induced	B-NP	JJ	O	4	NMOD	-1
4	accumulation	accumulation	I-NP	NN	O	2	OBJ	17	accumulation
5	of	of	B-PP	IN	O	4	NMOD	-1
6	hypoxia-inducible	hypoxia-inducible	B-NP	JJ	O	7	NMOD	-1
7	factor-1alpha	factor-1alpha	I-NP	NN	O	16	NMOD	-1
8	,	,	O	,	O	16	P	-1
9	vascular	vascular	B-NP	JJ	B-protein	12	NMOD	-1
10	endothelial	endothelial	I-NP	JJ	I-protein	12	NMOD	-1
11	growth	growth	I-NP	NN	I-protein	12	NMOD	0
12	factor	factor	I-NP	NN	I-protein	16	NMOD	-1
13	,	,	O	,	O	16	P	-1
14	and	and	O	CC	O	16	NMOD	-1
15	interleukin-8	interleukin-8	B-NP	NN	B-protein	16	NMOD	-1
16	expression	expression	I-NP	NN	O	5	PMOD	9	expression
17	in	in	B-PP	IN	O	16	NMOD	-1
18	hypoxic	hypoxic	B-NP	JJ	B-cell_type	22	NMOD	-1
19	human	human	I-NP	JJ	I-cell_type	22	NMOD	-1
20	colon	colon	I-NP	NN	I-cell_type	22	NMOD	-1
21	cancer	cancer	I-NP	NN	I-cell_type	22	NMOD	-1
22	cells	cell	I-NP	NNS	I-cell_type	17	PMOD	-1
23	.	.	O	.	O	2	P	-1

1	Frequent	Frequent	B-NP	JJ	O	3	NMOD	-1
2	coffee	coffee	I-NP	NN	O	3	NMOD	-1
3	consumption	consumption	I-NP	NN	O	4	SUB	-1
4	has	have	B-VP	VBZ	O	0	ROOT	-1
5	been	be	I-VP	VBN	O	4	VC	-1
6	associated	associate	I-VP	VBN	O	5	VC	0
7	with	with	B-PP	IN	O	6	VMOD	-1
8	a	a	B-NP	DT	O	10	NMOD	-1
9	reduced	reduce	I-NP	VBN	O	10	NMOD	0
10	risk	risk	I-NP	NN	O	7	PMOD	-1
11	of	of	B-PP	IN	O	10	NMOD	-1
12	colorectal	colorectal	B-NP	JJ	O	13	NMOD	-1
13	cancer	cancer	I-NP	NN	O	11	PMOD	-1
14	in	in	B-PP	IN	O	10	NMOD	-1
15	a	a	B-NP	DT	O	16	NMOD	-1
16	number	number	I-NP	NN	O	14	PMOD	-1
17	of	of	B-PP	IN	O	16	NMOD	-1
18	case-control	case-control	B-NP	JJ	O	19	NMOD	-1
19	studies	study	I-NP	NNS	O	17	PMOD	-1
20	.	.	O	.	O	4	P	-1

1	Coffee	Coffee	B-NP	NN	O	2	SUB	-1
2	is	be	B-VP	VBZ	O	0	ROOT	-1
3	a	a	B-NP	DT	O	5	NMOD	-1
4	leading	lead	I-NP	VBG	O	5	NMOD	0
5	source	source	I-NP	NN	O	2	PRD	-1
6	of	of	B-PP	IN	O	5	NMOD	-1
7	methylxanthines	methylxanthine	B-NP	NNS	O	6	PMOD	-1
8	,	,	O	,	O	7	P	-1
9	such	such	B-PP	JJ	O	10	PMOD	-1
10	as	as	I-PP	IN	O	7	NMOD	-1
11	caffeine	caffeine	B-NP	NN	O	10	PMOD	-1
12	.	.	O	.	O	2	P	-1

1	The	The	B-NP	DT	O	2	NMOD	-1
2	induction	induction	I-NP	NN	O	16	SUB	17	induction
3	of	of	B-PP	IN	O	2	NMOD	-1
4	vascular	vascular	B-NP	JJ	B-protein	7	NMOD	-1
5	endothelial	endothelial	I-NP	JJ	I-protein	7	NMOD	-1
6	growth	growth	I-NP	NN	I-protein	7	NMOD	0
7	factor	factor	I-NP	NN	I-protein	12	NMOD	-1
8	(	(	O	(	O	10	DEP	-1
9	VEGF	VEGF	B-NP	NN	B-protein	10	DEP	-1
10	)	)	O	)	O	7	NMOD	-1
11	and	and	O	CC	O	12	NMOD	-1
12	interleukin-8	interleukin-8	B-NP	NN	B-protein	3	PMOD	-1
13	(	(	O	(	O	15	DEP	-1
14	IL-8	IL-8	B-NP	NN	B-protein	15	DEP	-1
15	)	)	O	)	O	12	NMOD	-1
16	is	be	B-VP	VBZ	O	33	VMOD	-1
17	an	an	B-NP	DT	O	19	NMOD	-1
18	essential	essential	I-NP	JJ	O	19	NMOD	17	essential
19	feature	feature	I-NP	NN	O	16	PRD	-1
20	of	of	B-PP	IN	O	19	NMOD	-1
21	tumor	tumor	B-NP	NN	O	22	NMOD	-1
22	angiogenesis	angiogenesis	I-NP	NN	O	20	PMOD	3	angiogenesis
23	,	,	O	,	O	33	P	-1
24	and	and	O	CC	O	27	NMOD	-1
25	the	the	B-NP	DT	O	27	NMOD	-1
26	hypoxia-inducible	hypoxia-inducible	I-NP	JJ	O	27	NMOD	-1
27	factor-1	factor-1	I-NP	NN	O	32	NMOD	-1
28	(	(	O	(	O	30	DEP	-1
29	HIF-1	HIF-1	B-NP	NN	B-protein	30	DEP	-1
30	)	)	O	)	O	27	NMOD	-1
31	transcription	transcription	B-NP	NN	B-protein	32	NMOD	0
32	factor	factor	I-NP	NN	I-protein	33	SUB	-1
33	is	be	B-VP	VBZ	O	0	ROOT	-1
34	known	know	I-VP	VBN	O	33	VC	-1
35	to	to	I-VP	TO	O	36	VMOD	-1
36	be	be	I-VP	VB	O	34	VMOD	-1
37	a	a	B-NP	DT	O	39	NMOD	-1
38	key	key	I-NP	JJ	O	39	NMOD	-1
39	regulator	regulator	I-NP	NN	O	36	PRD	0
40	of	of	B-PP	IN	O	39	NMOD	-1
41	this	this	B-NP	DT	O	42	NMOD	-1
42	process	process	I-NP	NN	O	40	PMOD	-1
43	.	.	O	.	O	33	P	-1

1	In	In	B-PP	IN	O	6	VMOD	-1
2	this	this	B-NP	DT	O	3	NMOD	-1
3	study	study	I-NP	NN	O	1	PMOD	-1
4	,	,	O	,	O	6	P	-1
5	we	we	B-NP	PRP	O	6	SUB	-1
6	investigated	investigate	B-VP	VBD	O	0	ROOT	-1
7	the	the	B-NP	DT	O	8	NMOD	-1
8	effects	effect	I-NP	NNS	O	6	OBJ	16	effects
9	of	of	B-PP	IN	O	8	NMOD	-1
10	caffeine	caffeine	B-NP	NN	O	9	PMOD	-1
11	on	on	B-PP	IN	O	8	NMOD	-1
12	HIF-1	HIF-1	B-NP	NN	O	14	NMOD	-1
13	protein	protein	I-NP	NN	O	14	NMOD	-1
14	accumulation	accumulation	I-NP	NN	O	11	PMOD	17	accumulation
15	and	and	B-PP	CC	O	11	PMOD	-1
16	on	on	B-PP	IN	O	11	PMOD	-1
17	VEGF	VEGF	B-NP	NN	B-protein	20	NMOD	-1
18	and	and	I-NP	CC	O	20	NMOD	-1
19	IL-8	IL-8	I-NP	NN	B-protein	20	NMOD	-1
20	expression	expression	I-NP	NN	O	16	PMOD	9	expression
21	in	in	B-PP	IN	O	20	NMOD	-1
22	the	the	B-NP	DT	O	28	NMOD	-1
23	human	human	I-NP	JJ	B-cell_line	28	NMOD	-1
24	colon	colon	I-NP	NN	I-cell_line	28	NMOD	-1
25	cancer	cancer	I-NP	NN	I-cell_line	28	NMOD	-1
26	cell	cell	I-NP	NN	I-cell_line	28	NMOD	-1
27	line	line	I-NP	NN	I-cell_line	28	NMOD	-1
28	HT29	HT29	I-NP	NN	I-cell_line	21	PMOD	-1
29	under	under	B-PP	IN	O	20	NMOD	-1
30	hypoxic	hypoxic	B-NP	JJ	O	31	NMOD	-1
31	conditions	condition	I-NP	NNS	O	29	PMOD	-1
32	.	.	O	.	O	6	P	-1

1	Our	Our	B-NP	PRP$	O	2	NMOD	-1
2	results	result	I-NP	NNS	O	3	SUB	0
3	show	show	B-VP	VBP	O	0	ROOT	-1
4	that	that	B-SBAR	IN	O	3	VMOD	-1
5	caffeine	caffeine	B-NP	NN	O	7	SUB	-1
6	significantly	significantly	B-VP	RB	O	7	VMOD	-1
7	inhibits	inhibit	I-VP	VBZ	O	4	SBAR	18	inhibits
8	adenosine-induced	adenosine-induced	B-NP	JJ	O	11	NMOD	17	induced
9	HIF-1alpha	HIF-1alpha	I-NP	NN	O	11	NMOD	-1
10	protein	protein	I-NP	NN	O	11	NMOD	-1
11	accumulation	accumulation	I-NP	NN	O	7	OBJ	17	accumulation
12	in	in	B-PP	IN	O	11	NMOD	-1
13	cancer	cancer	B-NP	NN	B-cell_type	14	NMOD	-1
14	cells	cell	I-NP	NNS	I-cell_type	12	PMOD	-1
15	.	.	O	.	O	3	P	-1

1	We	We	B-NP	PRP	O	2	SUB	-1
2	show	show	B-VP	VBP	O	0	ROOT	-1
3	that	that	B-SBAR	IN	O	2	VMOD	-1
4	HIF-1alpha	HIF-1alpha	B-NP	NN	B-protein	6	NMOD	-1
5	and	and	I-NP	CC	O	6	NMOD	-1
6	VEGF	VEGF	I-NP	NN	B-protein	7	SUB	-1
7	are	be	B-VP	VBP	O	3	SBAR	-1
8	increased	increase	I-VP	VBN	O	7	VC	17	increased
9	through	through	B-PP	IN	O	8	VMOD	0
10	A3	A3	B-NP	NN	B-protein	13	NMOD	-1
11	adenosine	adenosine	I-NP	NN	I-protein	13	NMOD	-1
12	receptor	receptor	I-NP	NN	I-protein	13	NMOD	-1
13	stimulation	stimulation	I-NP	NN	O	9	PMOD	17	stimulation
14	,	,	O	,	O	2	P	-1
15	whereas	whereas	O	IN	O	2	VMOD	-1
16	the	the	B-NP	DT	O	17	NMOD	-1
17	effects	effect	I-NP	NNS	O	20	SUB	16	effects
18	on	on	B-PP	IN	O	17	NMOD	-1
19	IL-8	IL-8	B-NP	NN	B-protein	18	PMOD	-1
20	are	be	B-VP	VBP	O	15	SBAR	-1
21	mediated	mediate	I-VP	VBN	O	20	VC	16	mediated
22	via	via	B-PP	IN	O	21	VMOD	0
23	the	the	B-NP	DT	O	25	NMOD	-1
24	A2B	A2B	I-NP	NN	B-protein	25	NMOD	-1
25	subtype	subtype	I-NP	NN	O	22	PMOD	-1
26	.	.	O	.	O	2	P	-1

1	Pretreatment	Pretreatment	B-NP	NN	O	7	SUB	19	Pretreatment
2	of	of	B-PP	IN	O	1	NMOD	-1
3	cells	cell	B-NP	NNS	O	2	PMOD	-1
4	with	with	B-PP	IN	O	1	NMOD	-1
5	caffeine	caffeine	B-NP	NN	O	4	PMOD	-1
6	significantly	significantly	B-ADVP	RB	O	7	VMOD	-1
7	reduces	reduce	B-VP	VBZ	O	0	ROOT	18	reduces
8	adenosine-induced	adenosine-induced	B-NP	JJ	B-DNA	10	NMOD	17	induced
9	VEGF	VEGF	I-NP	NN	I-DNA	10	NMOD	-1
10	promoter	promoter	I-NP	NN	I-DNA	11	NMOD	-1
11	activity	activity	I-NP	NN	O	16	NMOD	0
12	and	and	O	CC	O	16	NMOD	-1
13	VEGF	VEGF	B-NP	NN	B-protein	16	NMOD	-1
14	and	and	O	CC	O	16	NMOD	-1
15	IL-8	IL-8	B-NP	NN	B-protein	16	NMOD	-1
16	expression	expression	I-NP	NN	O	7	OBJ	9	expression
17	.	.	O	.	O	7	P	-1

1	The	The	B-NP	DT	O	2	NMOD	-1
2	mechanism	mechanism	I-NP	NN	O	5	SUB	0
3	of	of	B-PP	IN	O	2	NMOD	-1
4	caffeine	caffeine	B-NP	NN	O	3	PMOD	-1
5	seems	seem	B-VP	VBZ	O	0	ROOT	-1
6	to	to	I-VP	TO	O	7	VMOD	-1
7	involve	involve	I-VP	VB	O	5	VMOD	16	involve
8	the	the	B-NP	DT	O	9	NMOD	-1
9	inhibition	inhibition	I-NP	NN	O	7	OBJ	18	inhibition
10	of	of	B-PP	IN	O	9	NMOD	-1
11	the	the	B-NP	DT	O	14	NMOD	-1
12	extracellular	extracellular	I-NP	JJ	B-protein	14	NMOD	-1
13	signal-regulated	signal-regulated	I-NP	JJ	I-protein	14	NMOD	-1
14	kinase	kinase	I-NP	NN	I-protein	23	NMOD	-1
15	1/2	1/2	I-NP	CD	I-protein	14	NMOD	-1
16	(	(	O	(	O	18	DEP	-1
17	ERK1/2	ERK1/2	B-NP	NN	B-protein	18	DEP	-1
18	)	)	O	)	O	14	NMOD	-1
19	,	,	O	,	O	23	P	-1
20	p38	p38	B-NP	NN	B-protein	23	NMOD	-1
21	,	,	O	,	O	23	P	-1
22	and	and	O	CC	O	23	NMOD	-1
23	Akt	Akt	B-NP	NN	B-protein	10	PMOD	-1
24	,	,	O	,	O	7	P	-1
25	leading	lead	B-VP	VBG	O	7	VMOD	17	leading
26	to	to	B-PP	TO	O	25	VMOD	-1
27	a	a	B-NP	DT	O	29	NMOD	-1
28	marked	marked	I-NP	JJ	O	29	NMOD	-1
29	decrease	decrease	I-NP	NN	O	44	NMOD	18	decrease
30	in	in	B-PP	IN	O	29	NMOD	-1
31	adenosine-induced	adenosine-induced	B-NP	JJ	O	33	NMOD	17	induced
32	HIF-1alpha	HIF-1alpha	I-NP	NN	O	33	NMOD	-1
33	accumulation	accumulation	I-NP	NN	O	30	PMOD	17	accumulation
34	,	,	O	,	O	44	P	-1
35	VEGF	VEGF	B-NP	NN	B-protein	37	NMOD	-1
36	transcriptional	transcriptional	I-NP	JJ	O	37	NMOD	10	transcriptional
37	activation	activation	I-NP	NN	O	44	NMOD	17	activation
38	,	,	O	,	O	44	P	-1
39	and	and	O	CC	O	44	NMOD	-1
40	VEGF	VEGF	B-NP	NN	B-protein	44	NMOD	-1
41	and	and	I-NP	CC	O	44	NMOD	-1
42	IL-8	IL-8	I-NP	NN	B-protein	44	NMOD	-1
43	protein	protein	I-NP	NN	O	44	NMOD	-1
44	accumulation	accumulation	I-NP	NN	O	26	PMOD	17	accumulation
45	.	.	O	.	O	5	P	-1

1	From	From	B-PP	IN	O	7	VMOD	-1
2	a	a	B-NP	DT	O	4	NMOD	-1
3	functional	functional	I-NP	JJ	O	4	NMOD	-1
4	perspective	perspective	I-NP	NN	O	1	PMOD	-1
5	,	,	O	,	O	7	P	-1
6	we	we	B-NP	PRP	O	7	SUB	-1
7	observe	observe	B-VP	VBP	O	0	ROOT	-1
8	that	that	B-SBAR	IN	O	7	VMOD	-1
9	caffeine	caffeine	B-NP	NN	O	12	SUB	-1
10	also	also	B-ADVP	RB	O	12	VMOD	-1
11	significantly	significantly	B-ADVP	RB	O	12	VMOD	-1
12	inhibits	inhibit	B-VP	VBZ	O	8	SBAR	18	inhibits
13	the	the	B-NP	DT	O	17	NMOD	-1
14	A3	A3	I-NP	NN	B-protein	17	NMOD	-1
15	receptor-stimulated	receptor-stimulated	I-NP	JJ	O	17	NMOD	17	stimulated
16	cell	cell	I-NP	NN	O	17	NMOD	-1
17	migration	migration	I-NP	NN	O	12	OBJ	14	migration
18	of	of	B-PP	IN	O	17	NMOD	-1
19	colon	colon	B-NP	NN	B-cell_type	21	NMOD	-1
20	cancer	cancer	I-NP	NN	I-cell_type	21	NMOD	-1
21	cells	cell	I-NP	NNS	I-cell_type	18	PMOD	-1
22	.	.	O	.	O	7	P	-1

1	Conditioned	Condition	B-NP	VBN	O	2	NMOD	-1
2	media	medium	I-NP	NNS	O	12	SUB	-1
3	prepared	prepare	B-VP	VBN	O	2	NMOD	-1
4	from	from	B-PP	IN	O	3	VMOD	-1
5	colon	colon	B-NP	NN	B-cell_type	6	NMOD	-1
6	cells	cell	I-NP	NNS	I-cell_type	4	PMOD	-1
7	treated	treat	B-VP	VBN	O	6	NMOD	19	treated
8	with	with	B-PP	IN	O	7	VMOD	-1
9	an	an	B-NP	DT	O	11	NMOD	-1
10	adenosine	adenosine	I-NP	NN	O	11	NMOD	-1
11	analog	analog	I-NP	NN	O	8	PMOD	-1
12	increased	increase	B-VP	VBD	O	0	ROOT	17	increased
13	human	human	B-NP	JJ	O	18	NMOD	-1
14	umbilical	umbilical	I-NP	JJ	O	18	NMOD	-1
15	vein	vein	I-NP	NN	O	18	NMOD	-1
16	endothelial	endothelial	I-NP	JJ	O	18	NMOD	-1
17	cell	cell	I-NP	NN	O	18	NMOD	-1
18	migration	migration	I-NP	NN	O	12	OBJ	14	migration
19	.	.	O	.	O	12	P	-1

1	These	These	B-NP	DT	O	2	NMOD	-1
2	data	datum	I-NP	NNS	O	3	SUB	-1
3	provide	provide	B-VP	VBP	O	0	ROOT	-1
4	evidence	evidence	B-NP	NN	O	3	OBJ	-1
5	that	that	B-SBAR	IN	O	20	DEP	-1
6	adenosine	adenosine	B-NP	NN	O	7	SUB	-1
7	could	could	B-VP	MD	O	5	SBAR	-1
8	modulate	modulate	I-VP	VB	O	7	VC	16	modulate
9	the	the	B-NP	DT	O	10	NMOD	-1
10	migration	migration	I-NP	NN	O	8	OBJ	14	migration
11	of	of	B-PP	IN	O	10	NMOD	-1
12	colon	colon	B-NP	NN	B-cell_type	14	NMOD	-1
13	cancer	cancer	I-NP	NN	I-cell_type	14	NMOD	-1
14	cells	cell	I-NP	NNS	I-cell_type	11	PMOD	-1
15	by	by	B-PP	IN	O	10	NMOD	-1
16	an	an	B-NP	DT	O	18	NMOD	-1
17	HIF-1alpha/VEGF/IL-8-dependent	HIF-1alpha/VEGF/IL-8-dependent	I-NP	JJ	O	18	NMOD	17	dependent
18	mechanism	mechanism	I-NP	NN	O	15	PMOD	0
19	and	and	O	CC	O	20	DEP	-1
20	that	that	B-SBAR	IN	O	4	NMOD	-1
21	caffeine	caffeine	B-NP	NN	O	22	SUB	-1
22	has	have	B-VP	VBZ	O	20	SBAR	-1
23	the	the	B-NP	DT	O	24	NMOD	-1
24	potential	potential	I-NP	NN	O	22	OBJ	0
25	to	to	B-VP	TO	O	26	VMOD	-1
26	inhibit	inhibit	I-VP	VB	O	24	NMOD	18	inhibit
27	colon	colon	B-NP	NN	O	30	NMOD	-1
28	cancer	cancer	I-NP	NN	O	30	NMOD	-1
29	cell	cell	I-NP	NN	O	30	NMOD	-1
30	growth	growth	I-NP	NN	O	26	OBJ	1	growth
31	.	.	O	.	O	3	P	-1

